Key result
Orthotopic heart transplantation delivers excellent long-term outcomes with ~74% survival at ten years.
Why the study?
To improve long-term results of heart transplantation by analyzing causes of death relative to time after transplantation.
Cohort (n=201)
No
Adult orthotopic heart transplantation demonstrates excellent long-term survival up to 10 years, with late mortality driven primarily by non-cardiac causes such as infection and malignancy rather than allograft vasculopathy.
Answers are grounded in this paper and cite their sources.
Supports counseling on durable adult heart transplant survival; extends single-center data but leaves open multicenter validation and non-cardiac risk reduction.
Heart transplantation is now regarded as the treatment of choice for end-stage heart failure. To improve long-term results of the heart transplantation, we analyzed causes of death relative to time after transplantation. A total of 201 consecutive patients, 154 (76.6%) males, aged ≥ 17 yr underwent heart transplantation between November 1992 and December 2008. Mean ages of recipients and donors were 42.8 ± 12.4 and 29.8 ± 9.6 yr, respectively. The bicaval anastomosis technique was used since 1999. Mean follow up duration was 6.5 ± 4.4 yr. Two patients (1%) died in-hospital due to sepsis caused by infection. Late death occurred in 39 patients (19.4%) with the most common cause being sepsis due to infection. The 1-, 5-, and 10-yr survival rates in these patients were 95.5% ± 1.5%, 86.9% ± 2.6%, and 73.5% ± 4.1%, respectively. The surgical results of heart transplantation in adults were excellent, with late mortality due primarily to infection, malignancy, and rejection. Cardiac deaths related to cardiac allograft vasculopathy were very rare.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2011) conducted a cohort in End-stage heart failure (n=201). Orthotopic heart transplantation was evaluated on Overall survival rate at 10 years. Orthotopic heart transplantation in adults resulted in excellent long-term outcomes, with 1-, 5-, and 10-year survival rates of 95.5%, 86.9%, and 73.5%, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: